Northamptonshire Hydroxychloroquine (HCQ) Monitoring Service - Information Pack Guide


Primary Eyecare Services has been commissioned by Northamptonshire Integrated Care Board (ICB) to deliver the Hydroxychloroquine (HCQ) Monitoring Service following a procurement process. The service provides community-based monitoring for patients receiving long-term hydroxychloroquine or chloroquine therapy, helping to identify retinal toxicity at an early stage and reduce the risk of irreversible sight loss.

Delivered through accredited community optometry practices, the service supports integrated care between primary and secondary care, maintains accurate patient monitoring registers, and ensures high-quality imaging, reporting, and secure record management.

Participating practices must be onboarded to OPERA, meet all required practice and practitioner compliance requirements, hold WOPEC HCQ accreditation, and have access to OCT, Fundus Autofluorescence (FAF) imaging, and 10-2 visual field testing equipment. The service aims to improve patient access to specialist monitoring closer to home while supporting safe, consistent, and efficient management of patients at risk of HCQ-related retinal toxicity.

This resource provides a comprehensive guide for the Northamptonshire HCQ Monitoring Service, including the service pathway, clinical protocols, referral criteria, equipment requirements, and practitioner responsibilities.

If you have any questions after reading the guide, please contact hello@referral.support or reach out via the blue bubble on the IT Platform.


Did this answer your question? Thanks for the feedback There was a problem submitting your feedback. Please try again later.